Published in Eur Respir J on August 01, 2007
Genetic ancestry in lung-function predictions. N Engl J Med (2010) 3.30
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52
Proportional classifications of COPD phenotypes. Thorax (2008) 2.10
Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res (2013) 1.13
Defining chronic obstructive pulmonary disease... and the elephant in the room. Eur Respir J (2007) 1.10
Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health (2015) 1.06
Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol (2009) 0.97
Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study. Scand J Prim Health Care (2010) 0.96
Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects. BMC Pulm Med (2012) 0.82
Subjects with Discordant Airways Obstruction: Lost between Spirometric Definitions of COPD. Pulm Med (2011) 0.82
Relationship of serum gamma-glutamyltransferase levels with pulmonary function and chronic obstructive pulmonary disease. Lung (2014) 0.80
Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis. Cancer (2015) 0.77
Sing Your Lungs Out: a qualitative study of a community singing group for people with chronic obstructive pulmonary disease (COPD). BMJ Open (2016) 0.77
Estimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40-95 years in England and Wales. BMJ Open (2014) 0.76
Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study. Int J Chron Obstruct Pulmon Dis (2015) 0.76
Spirometry, questionnaire and electronic medical record based COPD in a population survey: Comparing prevalence, level of agreement and associations with potential risk factors. PLoS One (2017) 0.75
Sing Your Lungs Out-a community singing group for chronic obstructive pulmonary disease: a 1-year pilot study. BMJ Open (2017) 0.75
Cognitive Impairment among Patients with Chronic Obstructive Pulmonary Disease Compared to Normal Individuals. Tanaffos (2017) 0.75
GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population. ERJ Open Res (2016) 0.75
How appropriate is the gold standard for diagnosis of airway obstruction? Lung India (2008) 0.75
Whakawhanaungatanga: the importance of culturally meaningful connections to improve uptake of pulmonary rehabilitation by Māori with COPD - a qualitative study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease. PLoS One (2016) 0.75
Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study. NPJ Prim Care Respir Med (2016) 0.75
A comparative study of COPD burden between urban vs rural communities in northern Thailand. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Population prevalence of COPD. Eur Respir J (2008) 0.75
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med (2017) 0.75
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41
Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med (1999) 29.97
Interpretative strategies for lung function tests. Eur Respir J (2005) 21.50
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84
Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis (1991) 13.67
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med (1995) 6.99
Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J (2006) 6.34
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet (2005) 5.61
American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. Am J Respir Crit Care Med (1995) 3.95
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med (2000) 3.79
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J (2002) 3.06
Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med (2003) 3.05
Interpreting COPD prevalence estimates: what is the true burden of disease? Chest (2003) 2.78
Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax (2006) 2.21
Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med (2006) 2.15
Population impact of different definitions of airway obstruction. Eur Respir J (2003) 2.11
Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. Eur Respir J (2004) 1.95
FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest (2006) 1.65
Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest (2000) 1.60
Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax (2005) 1.58
Complete reference ranges for pulmonary function tests from a single New Zealand population. N Z Med J (2006) 1.52
Nosology for our day: its application to chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.48
Physiological associations of computerized tomography lung density: a factor analysis. Int J Chron Obstruct Pulmon Dis (2006) 1.18
Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J (1997) 1.04
Pulmonary function tests: comparison of 95th percentile-based and conventional criteria of normality. South Med J (1997) 0.91
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther (2008) 4.54
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Tranquillizers. Br Med J (1962) 3.75
Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15
How much asthma is really attributable to atopy? Thorax (1999) 3.04
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
Risk of venous thromboembolism in users of hormone replacement therapy. Lancet (1996) 2.92
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
IMGT, the international ImMunoGeneTics database. Nucleic Acids Res (1997) 2.43
Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med (2003) 2.40
Personal factors as a cause of differences in prescribing by general practitioners. Br J Prev Soc Med (1968) 2.38
Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36
Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br J Pharmacol (1980) 2.31
Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27
Analysis of symptoms of patients with headaches and their response to treatment with ergot derivatives. Q J Med (1968) 2.19
Epidemiology of pneumothorax in England. Thorax (2000) 2.18
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Proportional classifications of COPD phenotypes. Thorax (2008) 2.10
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
The stereochemistry of the hydrogen elimination in the biological conversion of cholest-7-en-3-beta-ol into cholesterol. Biochem J (1967) 1.98
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
Axonal GABA-receptors in mammalian peripheral nerve trunks. Brain Res (1978) 1.97
Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79
Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy (2011) 1.68
Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67
Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child (2004) 1.62
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol (1988) 1.60
Pharmacogenetic pathway analysis of docetaxel elimination. Clin Pharmacol Ther (2008) 1.54
Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain (1999) 1.54
What do we need for robust, quantitative health impact assessment? J Public Health Med (2001) 1.52
Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis. Br Med J (1966) 1.52
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51
Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma. Clin Exp Allergy (2004) 1.51
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur Respir J (2004) 1.50
Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology (1997) 1.50
Recommendations for locus-specific databases and their curation. Hum Mutat (2008) 1.49
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
Is allergen exposure the major primary cause of asthma? Thorax (2000) 1.48
The effect of the increased prescription charges on the collection of asthma drugs. N Z Med J (1992) 1.48
A study of the management of asthma in a hospital emergency department. N Z Med J (1989) 1.47
Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions. J Allergy Clin Immunol (2001) 1.46
Dropping objects: possible mild cataplexy associated with clozapine. J Nerv Ment Dis (1990) 1.44
Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy (1999) 1.43
Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med (1991) 1.41
Use of a management plan for treating asthma in an emergency department. Thorax (1990) 1.40
Streptomycin and Promanide in Experimental Ocular Tuberculosis. Br J Ophthalmol (1950) 1.40
Fenoterol, asthma deaths, and asthma severity: confounding or confusion? Thorax (1997) 1.39
Fenoterol and asthma death. N Z Med J (1989) 1.39
Asthma deaths in New Zealand. BMJ (1992) 1.38
Fenoterol: confounding again. N Z Med J (1989) 1.38
Measles immunisation. Aust J Public Health (1992) 1.38
Detection and prevalence of early diabetic retinopathy in juvenile diabetics with diabetes for 10 years or more. Eye (Lond) (2000) 1.38
Inappropriate use of inhaled beta agonists in asthma. N Z Med J (1990) 1.37
Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy. Vet Rec (2003) 1.37
Prescribing for childhood asthma in the Wellington area: comparison with international guidelines. N Z Med J (1993) 1.37
A very simple method for recording ganglion depolarization. J Physiol (1975) 1.36
The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. Am Rev Respir Dis (1987) 1.33